Global EditionASIA 中文双语Français
World
Home / World / Americas

US faces funding shortages amid efforts to contain COVID-19 spread

Xinhua | Updated: 2022-04-01 10:35
Share
Share - WeChat
A person receives a coronavirus disease test during the COVID-19 pandemic, in the Manhattan borough of New York City, on Jan 13, 2022. [Photo/Agencies]

NEW YORK -- Funding shortages have posed challenges to the Joe Biden administration in its over-one-year-old battle against COVID-19, while various efforts are being patched up to stem the virus's spread amid a common belief the pandemic might be riding on its ending phase with falling cases and deaths.

The US federal government is running out of funds to provide Americans, especially those who are uninsured, with COVID-19 vaccines, tests and treatments, as the country's progress achieved over the last two years in the fight against COVID-19 is now threatened by Congress's failure to fund the continuing coronavirus response effort, reported The New York Times on Thursday.

Meanwhile, the World Health Organization (WHO) unveiled a new strategic plan on Wednesday that lays out a path toward ending the global emergency of COVID-19. In its third strategic preparedness and response plan on COVID-19, the WHO acknowledged the pandemic remains an acute global crisis but charted a path to end the global emergency if key measures are implemented rapidly.

SECOND BOOSTER

The US Food and Drug Administration (FDA) has authorized a second COVID-19 booster shot for people aged 50 and older, but several public health experts said younger, healthier members of that group don't necessarily need a fourth shot as soon as they become eligible.

"This is one of those where I don't think anyone needs to race," Richard Besser, former acting director of the US Centers for Disease Control and Prevention (CDC), told NBC's "TODAY" show on Wednesday. "This is one of those things where people should think thoughtfully."

The FDA's authorization, announced on Tuesday and promptly followed by new CDC guidance, allows anyone 50 and older to seek a fourth dose of the Pfizer-BioNTech or the Moderna vaccine at least four months after their initial booster. Immunocompromised people, for whom a three-shot regimen is considered the primary vaccination series, can seek a second booster as well.

TREATMENT ONLINE

As the coronavirus pandemic moves into what the White House hopes is a "new normal," the Biden administration has introduced covid.gov, a federal website meant to help Americans who are infected with the virus find the treatment they need quickly and at no cost.

"This website is part of our effort - our continued and ongoing effort - to make sure that people have what they need to deal with COVID as we move into potentially the next phase of this disease," the White House said on Wednesday.

This new phase, aimed at helping the United States transition to "living with the virus," has four main goals: protecting against and treating COVID-19, preparing for new variants, avoiding shutdowns and fighting the virus abroad, according to the White House announcement.

FREE CRUISES

The CDC dropped cruise voyages from its list of coronavirus travel health notices on Wednesday, the latest barrier to fall for an industry seeking a semblance of pre-pandemic norms. Cruise lines still require passengers to be vaccinated and test negative before boarding.

The CDC issues its notices "to alert travelers and other audiences to health threats around the world," ranking destinations between Levels 1 and 4 based on the number and trajectory of new cases. It had included notices for cruise ships since March 2020, when cruise lines stopped sailing from US waters for more than a year.

"CDC's decision to remove the travel health notice for cruise travel was based on the current state of the pandemic and overall decreases in COVID-19 cases onboard cruise ships over the past several weeks," The Washington Post quoted CDC spokesman David Daigle as saying in an email.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US